Recalls / Active ingredient / Mometasone Furoate
Mometasone Furoate
6 FDA drug recalls involving the active ingredient “Mometasone Furoate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-05-28 | Class III | Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 60 Metered Doses, Rx Only, Ma | Organon Llc |
| 2024-05-28 | Class III | Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 14 Metered Doses, Rx Only, Ma | Organon Llc |
| 2023-01-04 | Class III | SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, intersect ENT, 1555 Adams D | Intersect ENT, Inc. |
| 2022-06-16 | Class III | Mometasone Furoate, Topical Solution USP, 0.1 % Lotion, a) 30 ml-bottle (NDC 68462-385-37), b) 60 ml-bottle (N | Glenmark Pharmaceuticals Inc., USA |
| 2022-01-26 | Class II | Asmanex Twisthaler (mometasone furoate inhalation powder, 220 mcg per actuation), 120 Metered Doses, Rx only, | CARDINAL HEALTHCARE |
| 2019-07-23 | Class II | Mometasone Furoate Cream USP, 0.1%, packaged in a) 15gram tubes (NDC 68462-192-17) and b) 45 gram tubes (NDC 6 | Glenmark Pharmaceuticals Inc., USA |